This research effort, led by a multidisciplinary team including clinicians and computational scientists, sought to assess whether widely available large language models (LLMs) such as ChatGPT and Gemini could be harnessed to generate individualized meal plans and comprehensive grocery lists adapted to the complex needs of cancer patients. By inputting variables such as cancer stage, co-morbid health conditions, socioeconomic constraints, geographic location, and cultural food preferences, the team endeavored to push these AI models beyond generic recommendations toward nuanced, actionable dietary strategies. Their findings, published recently in a peer-reviewed journal, reveal the remarkable potential, as well as current limitations, of LLM-guided nutritional support.

At the heart of this study is the recognition that cancer nutrition is inherently multifactorial. Patients not only contend with fluctuating appetites, treatment side effects, and altered metabolism but also with diverse cultural and economic realities. Senior author Dr. Nicole Simone, a radiation oncologist affiliated with the Sidney Kimmel Comprehensive Cancer Center, underscores the transformative capacity of this technology. By leveraging AI’s ability to process vast datasets and contextualize patient-specific factors, the team aimed to bridge longstanding gaps in personalized care that often leave vulnerable patients underserved.

The first phase of the investigation involved detailed prompt engineering, conducted by Julia Logan, a medical student whose hands-on summer research tested the response fidelity of the LLMs across a wide array of patient scenarios. These prompts simulated real-world conditions that reflect the complexity clinicians face, including budgetary limits and local ingredient availability. The artificial intelligence systems were able to generate meal plans that reflected these parameters with a surprising level of granularity. For example, the AI considered the cost-effectiveness of ingredient choices while incorporating ethnic foods familiar to patients, thereby supporting not only nutritional goals but also cultural adherence and patient satisfaction.

Wookjin Choi, PhD, a computational physicist and co-author, emphasized the pragmatic strategy behind the research. Instead of developing a specialized AI model from the ground up, which is resource-intensive and time-consuming, the team adapted existing large language models. These robust generalist LLMs served as adaptable foundations, upon which layers of domain-specific evaluation and modification were applied. This iterative process involved scoring the outputs, calibrating prompt structures, and gradually creating a refined model attuned to oncology nutrition nuances.

One of the most striking outcomes reported by the researchers was the LLMs’ capacity to integrate geographical and socioeconomic data effectively. The AI successfully accounted for local grocery store inventories, ensuring recommended ingredients were realistically obtainable by patients—a critical component often overlooked in digital health solutions. This adaptability signifies a paradigm shift, where AI tools may not only tailor medical advice to the individual’s biology but to their lived environment, enhancing practical utility.

The research team acknowledged, however, that AI-generated nutritional plans are not infallible. While the outputs demonstrated impressive alignment with dietitian-level recommendations in many cases, inherent risks exist regarding errors or omissions that could affect patient safety. Thus, the study posits an AI-human collaborative approach: using LLMs as scalable aides for preliminary dietetic guidance with subsequent professional oversight to verify and customize care plans further. This model could alleviate the burden on clinical nutritionists by streamlining routine advisory tasks while preserving the critical human element.

Furthermore, the study’s implications extend beyond oncology. The methodological framework of customizing AI-driven dietary advice based on multidimensional patient characteristics could revolutionize nutritional care across chronic diseases. The integration of socioeconomic factors and cultural sensitivity ensures recommendations resonate deeply with diverse patient populations, potentially reducing disparities in health outcomes linked to nutrition access and education.

Ethical considerations accompanying AI’s increasing role in healthcare naturally arise. Transparency in how dietary advice is generated, the explainability of AI decisions, and the safeguarding of patient data are vital components that the researchers plan to address in subsequent work. Additionally, ongoing evaluation of AI reliability and clinical validation remain paramount before widespread adoption.

In sum, this pioneering research underscores a promising frontier where artificial intelligence catalyzes patient-centered nutrition support in oncology. By systematically merging clinical insights, computational power, and real-world constraints, Thomas Jefferson University’s endeavor illuminates a path toward more equitable, personalized, and effective dietary assistance for cancer patients. While challenges remain, notably in defining the thresholds for AI autonomy versus professional supervision, this work lays critical groundwork for the future convergence of technology and compassionate cancer care.

As AI models continue to evolve in accuracy and contextual understanding, their deployment in healthcare settings must be executed thoughtfully. The success of this project not only highlights the potential of LLMs but elevates the conversation about integrating digital tools into clinical workflows. Embracing AI as an adjunct facilitator could ultimately enhance patient empowerment and adherence, especially for those grappling with the multidimensional burdens of cancer.

The journey ahead includes rigorous validation studies, broader demographic testing, and exploration of longitudinal impacts on patient health outcomes. Moreover, fostering interdisciplinary collaborations will be essential to translate these technological advances into clinical standards and patient education. By navigating these complexities, the medical community can harness AI’s transformative capacity while maintaining the trust and safety central to patient care.

The narrative emerging from this research is one of hope and innovation, where technology acts as a bridge over existing healthcare gaps. The ability to democratize expert-level dietary guidance means that nutritional intervention—a cornerstone of cancer therapy support—may become more accessible, scalable, and individualized than ever before. The implications resonate well beyond clinical nutrition, offering a template for AI-driven, culturally competent, and socioeconomically sensitive healthcare in the 21st century.

Subject of Research: Use of Large Language Models for Personalized Nutritional Guidance in Cancer Patients

Article Title: (Not specified in the content)

News Publication Date: (Not specified in the content)

Web References:

• https://www.mdpi.com/2072-6643/17/7/1176
• https://research.jefferson.edu/labs/researcher/simone-laboratory/team.html
• https://www.jefferson.edu/academics/colleges-schools-institutes/skmc/departments/radiation-oncology/faculty/directory/choi.html

References: (No additional references provided)

Image Credits: (No images provided)

Keywords: Generative AI, Cancer patients, Artificial intelligence, Oncology, Nutritional support

The program, known as the Geriatric Assessment-Guided Intervention-Supportive Care (GAIN-S), integrates a multidisciplinary approach encompassing personalized fitness regimens, nutritional counseling, psychiatric support, and psychosocial assistance. Delivered entirely via telehealth modalities, GAIN-S offers an innovative model that dismantles traditional barriers, such as travel burden and limited local expertise, often faced by elderly patients scattered across remote or underserved territories. This carefully orchestrated regimen was scrutinized in a rigorously designed randomized clinical trial involving 77 participants aged 65 years and older, all receiving treatment for metastatic solid tumors in Brazil from mid-2022 to mid-2023.

The trial’s choice of Brazil as a testing ground was both strategic and poignant. With healthcare infrastructure concentrated predominantly in major urban centers, a vast swath of the population endures limited access to specialized oncology and geriatric care. The study’s reliance on urban-based care providers, who delivered interventions remotely, allowed for a direct examination of telehealth’s capacity to equalize access and elevate care standards across socioeconomically and geographically disparate regions. Results at the three-month evaluation point revealed significant improvements across vital outcome measures, including enhanced physical function, mood stabilization, deeper illness comprehension, and overall quality of life.

One of the critical technical pillars underpinning this success was the utilization of encrypted, secure messaging platforms—in this case, WhatsApp—to schedule appointments and obtain informed consent. By employing end-to-end encryption and ephemeral messaging features, the team ensured patient confidentiality and data security, addressing a pervasive concern in digital health interventions. This operational detail underscores the essential convergence of technological innovation with clinical expertise, enabling scalable and privacy-conscious telehealth solutions.

Senior author Dr. William Dale, MD, PhD of City of Hope, emphasized the transformative potential of such telehealth programs, stating that bringing expert care directly into patients’ homes circumvents the logistic and financial barriers that so often compromise treatment adherence and outcomes. This decentralized method not only enhances equity but also optimizes the allocation of specialized resources, ensuring that providers’ expertise can reach far-flung populations without necessitating physical relocation of either party. The implications extend beyond cancer care to broader chronic disease management paradigms.

Lead author Dr. Cristiane Decat Bergerot, PhD, of Oncoclinicas&Co in Sao Paulo, reinforced the notion that integrating supportive care early in the cancer care trajectory is essential. Early intervention via remote platforms fosters improved communication channels between patients, families, and healthcare teams, setting the stage for more effective symptom management, emotional support, and personalized treatment planning. Such timely engagement is especially critical in geriatric oncology, where comorbidities and frailty complicate clinical decision-making.

Commenting on the study, independent expert Dr. Martine Extermann, MD, PhD, from Moffitt Cancer Center, highlighted the broader clinical significance of GAIN-S within the framework of Comprehensive Geriatric Assessment and Management (CGAM). CGAM, a well-established evidence-based standard compensating for the heterogeneity of aging cancer patients, traditionally remained confined to large academic institutions due to resource demands. This trial compellingly demonstrates that telehealth modalities can democratize CGAM’s benefits, facilitating its adoption in community settings and emerging economies alike, thereby expanding its global reach.

Furthermore, the randomized controlled design fortifies the evidence base underpinning telehealth interventions in geriatric oncology, outperforming prior observational or pilot investigations. The methodological rigor and clear outcome improvements make a compelling case for policy makers and healthcare systems to recalibrate resource allocation strategies, incorporating telehealth-supported supportive care as an integral component of oncologic treatment frameworks targeting older adults.

This study also shines a spotlight on the technological and infrastructural prerequisites necessary for widespread telehealth implementation. Reliable internet connectivity, user-friendly digital platforms, and secure communication channels must coalesce seamlessly with clinical workflows to realize the full potential of remote care. The deployment in Brazil, a middle-income country with diverse connectivity landscapes, offers real-world insights into overcoming such logistical challenges and tailoring solutions to local contexts.

In addition to clinical and technical factors, the social dimensions of telehealth interventions receive due consideration. The ease with which older patients adapted to remote interactions, the psychological relief afforded by reduced travel requirements, and the enhanced caregiver involvement collectively underscore telehealth’s holistic benefits. Importantly, these factors contribute to improved adherence, satisfaction, and ultimately, better health trajectories.

The implications of this research ripple beyond national boundaries. As the global population ages and cancer incidence rises disproportionately among older adults, scalable, equitable care strategies are urgently required. The GAIN-S program exemplifies such innovation, representing a beacon for international oncology communities eager to adopt sustainable, patient-centered telehealth frameworks that reconcile clinical excellence with accessibility.

To access the full details of the GAIN-S randomized clinical trial, alongside an expert commentary by Dr. Extermann, readers are encouraged to consult the June 2025 issue of JNCCN via JNCCN.org. This research not only advances scientific understanding but also sets a precedent for harnessing technology to meet the nuanced challenges of geriatric cancer care in a digitally connected world.

Subject of Research: People

Article Title: Telehealth Geriatric Assessment and Supportive Care Intervention (GAIN-S) Program: A Randomized Clinical Trial

News Publication Date: 11-Jun-2025

Web References:

• JNCCN
• Telehealth GAIN-S Study
• The Last Word Commentary

Image Credits: NCCN

Keywords: Cancer, Carcinoma, Cancer research, Cancer treatments, Oncology, Aging populations, Gerontology, Older adults, Economic geography, Underdeveloped areas, Telecommunications